Gene · 2852
Papers4,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Utility of G protein-coupled oestrogen receptor 1 as a biomarker for pan-cancer diagnosis, prognosis and immune infiltration: a comprehensive bioinformatics analysis. | Aging (Albany NY) | 2023 | 37921845 | PubTator, text mining | PubMed |
| Associations between genetically predicted sex and growth hormones and facial aging in the UK Biobank: a two-sample Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 37916150 | PubTator, text mining | PubMed |
| Differential effects of follicle-stimulating hormone glycoforms on the transcriptome profile of cultured rat granulosa cells as disclosed by RNA-seq. | bioRxiv | 2023 | 37905087 | PubTator, text mining | PubMed |
| The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer. | Front Endocrinol (Lausanne) | 2023 | 37900137 | PubTator, text mining | PubMed |
| Tailoring Potential Natural Compounds for the Treatment of Luminal Breast Cancer. | Pharmaceuticals (Basel) | 2023 | 37895937 | PubTator, text mining | PubMed |
| Cancer Stem Cells and Androgen Receptor Signaling: Partners in Disease Progression. | Int J Mol Sci | 2023 | 37894767 | PubTator, text mining | PubMed |
| Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity. | Int J Mol Sci | 2023 | 37894728 | PubTator, text mining | PubMed |
| Novel Insights into the Role of Chromatin Remodeler MORC2 in Cancer. | Biomolecules | 2023 | 37892209 | PubTator, text mining | PubMed |
| Inhibition of GPR30 sensitized gefitinib to NSCLC cells via regulation of epithelial-mesenchymal transition. | Int J Immunopathol Pharmacol | 2023 | 37890097 | PubTator, text mining | PubMed |
| The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer. | Cells | 2023 | 37887304 | PubTator, text mining | PubMed |
| The emerging potential of siRNA nanotherapeutics in treatment of arthritis. | Asian J Pharm Sci | 2023 | 37881798 | PubTator, text mining | PubMed |
| Prunetin in a GPR30-dependent manner mitigates renal ischemia/reperfusion injury in rats via interrupting indoxyl sulfate/TLR4/TRIF, RIPK1/RIPK3/MLKL, and RIPK3/PGAM5/DRP-1 crosstalk. | Saudi Pharm J | 2023 | 37868646 | PubTator, text mining | PubMed |
| Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine. | Oncogene | 2023 | 37864030 | PubTator, text mining | PubMed |
| In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER. | Sci Rep | 2023 | 37863936 | PubTator, text mining | PubMed |
| CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts. | Endocr Relat Cancer | 2023 | 37855325 | PubTator, text mining | PubMed |
| Estrogen Receptor Signaling in Breast Cancer. | Cancers (Basel) | 2023 | 37835383 | PubTator, text mining | PubMed |
| Unveiling the Anti-Cancer Potential of Onoceranoid Triterpenes from Lansium domesticum Corr. cv. kokosan: An In Silico Study against Estrogen Receptor Alpha. | Int J Mol Sci | 2023 | 37834479 | PubTator, text mining | PubMed |
| GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments. | Int J Mol Sci | 2023 | 37834441 | PubTator, text mining | PubMed |
| Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer. | Int J Mol Sci | 2023 | 37834225 | PubTator, text mining | PubMed |
| The Role of Adipokines in the Pathologies of the Central Nervous System. | Int J Mol Sci | 2023 | 37834128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2852/papers?page=24